3 Top Biotech Stocks to Buy in August
As investors, it benefits us to pay attention to trends -- particularly those massive trends that have been under way for some time and that are likely to continue.
Arguably one of the best examples is what demographers refer to as the "grey tsunami," which is a term for the large wave of baby boomers in the U.S. who have reached the age of at least 65. The U.S. Census Bureau points out that by 2030, the 73 million living baby boomers as of the 2020 Census will all be 65-plus years of age.
Of course, the older people are, the more they typically require healthcare interventions such as medications and surgeries. These demographic developments therefore matter very much to healthcare companies such as AbbVie (NYSE: ABBV), AstraZeneca (NASDAQ: AZN), and Viatris, (NASDAQ: VTRS), all of which I believe are reasonably valued picks for August.
Source Fool.com
